REMINDER: Our user survey closes on Friday, please submit your responses here.
There could be a raise coming If so I shall buy it but it is too risky for me to sell to buy back in at 30% lower if it doesn’t happen . At this stage there is also a possibility of a farm in or JV . It’s 50/50. For me it’s a hold .
I read through it a couple of times , going to read it again later on tonight. They appear to be expecting a milestone payment or two in the near term . I hope they weren’t too negative in their risk assessment although that is standard practice.
What are people’s thoughts on the annual report?
Totally agree.
Article quotes Chief Executive Lisa Anson as saying that, to access larger specialist biotechnology investors, "you do need to be ultimately US-listed. So we will look at that as a board." The Times calls the possibility of Redx shares leaving AIM "the latest blow to the City".
Lisa states currently not seeking to list in the US but acknowledging to access bigger investment companies you do need to be listed in US.
Gap filled , may be bottom in.
Why all the ramping yesterday then?
I expect HE1 will head back to placing by next week when the extra shares float.
Bought in today 27p. Little bit too early but happy with that.
Thanks DJ all accepted.👍
Hi Guys I have found the group. Initials are NM , I hold 1.6 mill. Thank you for all your efforts so far and if I may I would wish to join the group. Thank you.
Try Deccan Gold
Thank you DJ Walls. Even if there is no lock in , as much as I swore if this realists I am out, I am more than tempted now to let it run. It’s a share I had given up on and now with all that us going on in the world gold is only going up so this could turn out to be a winner. If we relist.
If this gets to IPO which I pray it does , I believe there is a six month lock in period on any new IPO. Could be wrong , but it is to avoid if possible any volatility. I could be wrong.
Steve if you are referring to moi , I don’t post often but here a long time and yes I have an awful lot of these as well.
Thanks , didn’t spot that reading on I phone, but I’d expect costs to navigate towards break even if not by year end , certainly H1 2023 . All good imo GLA
Unless I have missed it , I didn’t read any where mentioning a raise. I also note unless someone else has mentioned it operational costs has more than halved and loss per share is 0.3 as opposed to 1.21 . Given as stated revenues are going to ramp up H2 those numbers are are going to be closer to Zero . What is not to like about that ?